Diabetes Specialist Nurse

Academic Career: 1987 General Qualification for University Entrance (Matura at the Naturwissenschaftliches Bundesrealgymnasium Wörgl) 1987 – 1995 Medical School, Leopold Franzens University of Innsbruck 1991 – 1995 Research Fellow at the Institute of Physiology, University of Innsbruck 1995 - 1996 Resident at the Institute of Physiology, University of Innsbruck 1996-2003 Resident at the University Children’s Hospital, Innsbruck 08/2001-10/2001 Research Fellow at the Institute Pasteur, Lille, France 10/2001-10/2002 Research Fellow at the Institute of Endocrinology and Diabetes at the Children´s Hospital at Westmead, Sydney, Australia since 2003 Consultant of Paediatrics, University Children’s Hospital, Medical University of Innsbruck since 2007 Consultant of Paediatric Endocrinology and Diabetes, University Children’s Hospital, Medical University of Innsbruck 10/2009 Postdoctoral Lecture Qualification 11/2009 Clinical Investigators Training and Qualification since 2012 Associate Professor of Paediatrics, Medical University of Innsbruck 2012-2014 Vice President of the Austrian Working group for Paediatric Endocrinology and Diabetes (APEDÖ)

Dr. Holt is Head of Global Medical, Clinical, and Safety at LifeScan, overseeing global medical safety, developing strategic medical initiatives, and initiating a medical science liaison program. Dr. Holt attended Duke University and earned her MD degree at Wake Forest University. She is board certified in Endocrinology, and practiced general Endocrinology for many years in Raleigh, NC. Dr. Holt then transitioned to the pharmaceutical industry in Medical Affairs. Additional roles include Assistant Consulting Professor of Medicine at Duke University School of Medicine, Co-Director for Taking Control of Your Diabetes, and Board of Directors for American Association of Clinical Endocrinologists. Dr. Holt has been named five times as one of America's Top Physicians, has received a Patient's Choice Award four times, was named three times as Top Endocrinologist, has received a Top Doctor Award, and was given a Lifetime Achievement Award from Who’s Who.

Roman Hovorka PhD FMedSci is Professor of Metabolic Technology Research at the Institute of Metabolic Science and Department of Paediatrics at University of Cambridge. He made seminal contributions to diabetes technology including the “Artificial Pancreas”, a device that delivers insulin in glucose responsive fashion. He is Chief Investigator on several trials evaluating the Artificial Pancreas in populations such as young children and newly diagnosed type 1 diabetes.

Erik Huneker is the co-founder and CEO of Diabeloop, a company developing interoperable self-learning algorithm solutions for diabetes management. Diabeloop solutions use artificial intelligence to automate and personalize insulin delivery, according to people physiology and customized parameters for a radically improved treatment and quality of life. Erik previously spent 7 years in the medical devices field at GE Healthcare, where he managed the international localization business to a ten-fold growth in sales. He started his professional career at Pechiney and Alcan, with 7 years of management positions in manufacturing, marketing and lean in the US and in France. He graduated from the Ecole Polytechnique in Paris. He gets energized by listening to the feedback of patients and Diabeloop devices potential to improve their lives.